Glutathione-S-transferase activity and isoenzyme levels measured by two methods in ovarian cancer, and their value as markers of disease outcome

British Journal of Cancer

Volumn 73, Issue 6, 1996, Pages 763-769

  Wrigley, E C ^a   McGown, A T ^b   Buckley, H ^c   Hall, A ^d   Crowther, D ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Glutathione transferase; Ovarian cancer; Prognosis

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC METAL COMPLEX; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GLUTATHIONE TRANSFERASE; IFOSFAMIDE; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OVARY CANCER; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; TUMOR BIOPSY;

EID: 0029865740     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.133     Document Type: Article

References (19)

1. GILBERT L, ELWOOD LJ, MERINO M, MASOOD S, BARNES R, STEINBERG SM, LAZAROUS DF, PIERCE L, D'ANGELO T, MOSCOW JA, TOWNSEND AJ AND COWAN KH. (1993). A pilot study of pi-class clutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J. Clin. Oncol., 11, 49-58.
2. GREEN JA, ROBERTSON LJ AND CLARK AH. (1993). Glutathione-S-transferase expression in benign and malignant ovarian tumours. Br. J. Cancer, 68, 235-239.
3. HABIG WH, PABST MJ AND JAKOBY WB. (1974). Glutathione S-transferases. The first step in mercapturic acid formation. J. Biol. Chem., 249, 7130-7139.
4. HALL A, AUTZEN P, CATTAN A, MALCOLM A, COLE M, KERNAHAM J AND REID M. (1994). Expression of μClass glutathione S-transferase correlates with event-free survival in childhood acute lymphoblastic leukaemia. Cancer Res., 54, 5251-5254.
5. HAMADA SI, KAMADA M, FURUMOTO H, HIRAO T AND AONO T. (1994). Expression of Glutathione-S-Transferase-π in human ovarian cancer as an indicator or resistance to chemotherapy. Gynecol. Oncol., 52, 313-319.
6. HIRATA S, ODAJIMI T, KOHAMA G, ISHIGAKI S AND NIITSU Y. (1992). Significance of Glutathione S-Transferase - π as a tumour marker in patients with oral cancer. Cancer, 70, 2381-2387.
7. KAPLAN E AND MEIER P. (1958). Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc., 5, 457-481.
8. KOBERDA J AND HELLMAN A. (1991). Glutathione-S-transferase activity of leukaemia cells as a prognostic factor for response to chemotherapy in acute leukaemias. Med. Oncol. Tumour Pharmacother., 8, 35-38.
9. LAEMMLI VK. (1970). Cleavage of structural proteins during the assembly of the head of bacteriaphage T4. Nature, 227, 680-685.
10. LEWIS AD, HAYES JD AND WOLF RD. (1988). Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug-resistance: intrinsic differences and cell cycle effect. Carcinogenesis, 9, 1283.
11. MANNERVIK B AND DANIELSON UH. (1988). Glutathione transferase-structure and catalytic activity. Critical Rev. Biochem., 23, 283.
12. MEIJER C, MULDER NH AND DE VRIES EGE. (1990). The role of detoxifying systems in resistance of tumour cells to cisplatin and adriamycin. Cancer Treat. Rev., 17, 389.
13. MELINA R, OESTEREICH S, ZHOU JL, TANDON AK, CLARK GM, ALLRED DC, TOWNSEND AJ, MOSCOW AJ, COWAN KH, MCGUIRE WL AND FUQUA SAW. (1993). Glutathione Transferase GST π in breast tumours evaluated by three techniques. Dis. Markers, 11, 71-82.
14. MURPHY D, MCGOWN AT, HALL A, CATTAN A, CROWTHER D AND FOX B. (1992). Glutathione-S-transferase activity and isoenzyme distribution in ovarian tumour biopsies taken before or after cytotoxic chemotherapy. Br. J. Cancer, 66, 937-942.
15. OKUYAMA T, MAEHARA Y, ENDO K, BABA H, ADACHI Y, OKUWANO M AND SUGIMACHI K. (1994). Expression of Glutathione-S-transferase-pi and sensitivity of human genetic cancer cells to aspiatin. Cancer, 74, 1230-1236.
16. PETERS WHM, ROELOFS HMJ, VAN PUTTEN WLJ, JANSEN JBMJ, KLIJN JGM AND FOEKENS JA. (1993). Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione-S-transferases. Br. J. Cancer, 68, 86-92.
17. TIDEFELT U, ELMHORN-ROSENBORG A, PAUL C, HAO X-Y, MANNERVIK B AND ERIKSSON L. (1992). Expression of Glutathione Transferase π as a predictor for treatment results at different stages of acute nonlymphoblastic leukaemia. Cancer Res., 52, 3281-3285.
18. VAN DER ZEE AGJ, OMMEN B, MEIJER C, HOLLEMA M, VAN BLADEREN PJ AND DE VRIES EGE. (1992). Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy. Br. J. Cancer., 66, 930-936.
19. VAN DER ZEE AGJ, HOLLEMA H, SUURMEIJER AJH, KRANS M, SLUITER WJ, WILLEMSE PHB, AALDERS JG AND DE VRIES EGE. (1995). Value of ρ-Glycoprotein, Glutathione-S-transferase pi, C-erbB-2 and ρ53 as prognostic factors in ovarian carcinomas. J. Clin. Oncol., 13, 70-78.